Suzhou Highfine Biotech Co., Ltd. (SHE:301393)
China flag China · Delayed Price · Currency is CNY
58.63
-0.97 (-1.63%)
Apr 16, 2026, 4:00 PM EDT

Suzhou Highfine Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
6,2725,4224,2696,481--
Market Cap Growth
36.06%27.01%-34.13%---
Enterprise Value
5,0193,9412,5254,742--
Last Close Price
58.6350.6939.6159.09--
PE Ratio
54.8247.3031.8565.48--
Forward PE
-23.6923.6934.44--
PS Ratio
10.419.009.4516.67--
PB Ratio
2.662.301.882.93--
P/TBV Ratio
2.862.481.942.96--
P/FCF Ratio
--229.29---
P/OCF Ratio
80.7569.8133.7873.79--
EV/Sales Ratio
8.336.545.5912.20--
EV/EBITDA Ratio
32.7025.8020.8751.46--
EV/EBIT Ratio
43.0333.7924.5859.86--
EV/FCF Ratio
-37.75-135.61---
Debt / Equity Ratio
0.020.020.000.000.000.01
Debt / EBITDA Ratio
0.330.330.030.020.010.02
Debt / FCF Ratio
--0.18-0.030.10
Net Debt / Equity Ratio
-0.53-0.53-0.75-0.80-0.33-0.32
Net Debt / EBITDA Ratio
-8.24-8.24-14.08-19.19-1.04-0.90
Net Debt / FCF Ratio
9.479.47-91.5254.18-2.76-5.39
Asset Turnover
0.240.240.200.270.840.94
Inventory Turnover
2.832.832.352.132.653.02
Quick Ratio
6.286.2825.5427.861.962.31
Current Ratio
7.087.0827.3229.833.233.42
Return on Equity (ROE)
4.79%4.79%5.98%7.35%30.27%35.18%
Return on Assets (ROA)
2.91%2.91%2.77%3.43%16.65%20.20%
Return on Invested Capital (ROIC)
10.16%12.02%17.68%18.16%42.78%53.47%
Return on Capital Employed (ROCE)
4.80%4.80%4.50%3.60%28.90%33.50%
Earnings Yield
1.83%2.11%3.14%1.53%--
FCF Yield
-2.12%-2.45%0.44%-0.50%--
Dividend Yield
0.67%-0.98%0.42%--
Payout Ratio
37.89%37.89%29.98%27.28%15.65%0.01%
Buyback Yield / Dilution
0.76%0.84%-16.87%-14.40%-0.16%0.10%
Total Shareholder Return
1.43%0.84%-15.89%-13.98%-0.16%0.10%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.